Advertisement
Advertisement
U.S. markets open in 1 hour 12 minutes
S&P Futures
3,938.00 -40.00 (-1.01%) Dow Futures
31,951.00 -368.00 (-1.14%) Nasdaq Futures
12,759.00 -95.00 (-0.74%) Russell 2000 Futures
1,706.40 -26.10 (-1.51%) Crude Oil
67.54 -2.42 (-3.46%) Gold
1,997.70 +1.80 (+0.09%)
Copeland SMID Cap Dividend Growth Fund (CSDGX)
Nasdaq - Nasdaq Delayed Price. Currency in USD
Follow
At close: 08:00PM EDT
Advertisement
| Previous Close | 13.08 |
| YTD Return | 1.72% |
| Expense Ratio (net) | 0.95% |
| Category | Small Blend |
| Last Cap Gain | 5.00 |
| Morningstar Rating | ★★★★★ |
| Morningstar Risk Rating | Low |
| Sustainability Rating |
| Net Assets | 53.58M |
| Beta (5Y Monthly) | 0.97 |
| Yield | 1.21% |
| 5y Average Return | N/A |
| Holdings Turnover | 40.00% |
| Last Dividend | 0.17 |
| Average for Category | N/A |
| Inception Date | Feb 27, 2017 |
- GlobeNewswire
NextCure to Present at the BofA Securities 2022 Healthcare Conference
BELTSVILLE, Md., May 03, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference in Las Vegas on Tuesday May 10th at 10:40 am PT. A live audio webcast will be available through the Investors section of the company’s we
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
